Sida i infecció per VIH
Publicacions destacades
-
Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City: a Cross-Sectional Study
De la Mora, L; Laguno, M; De Lazzari, E; Ugarte, A; Leal, L;(...)Miquel, L; Bosch, J; Short, D; Mallolas, J; Martinez-Rebollar, M.Referència:Sexuality Research And Social Policy 2023.
-
PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement
Laguno, M; Ugarte, A; Martinez-Rebollar, M; Sobrino, Y; Font, G;(...)Rojas, J; Cordón, E; Blanco, JL; Martínez, E; Mallolas, J.Referència:Enfermedades Infecciosas Y Microbiologia Clinica 2023.
-
Do ART and Chemsex Drugs Get Along? Potential Drug-Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study
De la Mora, L; Nebot, MJ; Martinez-Rebollar, M; De Lazzari, E; Tuset, M;(...)Short, D; Salgado, E; Martinez, E; Blanco, JL; Mallolas, J.Referència:Infectious Diseases And Therapy 2022.
-
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain
de la Mora, L; Ugarte, A; Martínez-Rebollar, M; De Lazzari, E; García-Hernández, D;(...)González-Cordón, A; Martínez, E; Blanco, JL; Mallolas, J; Laguno, M.Referència:Aids And Behavior 2022.
-
Long term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in HCV-HIV coinfected patients
Laguno, M; Martínez-Rebollar, M; Casanova, M; de Lazzari, E; González-Cordón, A;(...)Ugarte, A; Ambrosioni, J; Blanco, JL; Martínez, E; Mallolas, J.Referència:Clinical Microbiology And Infection 2022.
-
Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre
Ambrosioni, J; Liévano, JR; Berrocal, L; Inciarte, A; de la Mora, L;(...)de Lazzari, E; Miró, JM; Blanco, JL; Martinez, E; Mallolas, J.Referència:Journal Of Antimicrobial Chemotherapy 2022.
-
Impact of the sars-cov-2 epidemic outbreak on prevention and care for hiv and other sexually transmitted infections at a large spanish hospital
de Lazzari, E; Martinez-Mimbrero, A; Chivite, I; Gonzalez-Cordon, A; Mosquera, M M;(...)Hurtado, J C; Mallolas, J; Miro, J M; Marcos, M A; Martinez, E.Referència:Antiviral Therapy 2021.
-
Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection
Ambrosioni, Juan; Farrera, Julia; de Lazzari, Elisa; Nicolas, David; Manzardo, Christian;(...)Marcos, Maria A; Sanchez-Palomino, Sonsoles; Fernandez, Emma; Plana, Montserrat; Miro, Jose M.Referència:Aids 2020.
-
Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV: a single-center, prospective observational study
Inciarte, Alexy; Gonzalez-Cordon, Ana; Rojas, Jhon; Torres, Berta; de Lazzari, Elisa;(...)Marcos, Maria A; Ambrosioni, Juan; Miro, Josep M; Martinez, Esteban; Blanco, Jose L.Referència:Aids 2020.
-
COVID-19 in patients with HIV: clinical case series
Blanco, Jose L; Ambrosioni, Juan; Garcia, Felipe; Martinez, Esteban; Soriano, Alex;Mallolas, Josep; Miro, Jose M.Referència:Lancet Hiv 2020.